A San Antonio researcher has announced that he has found a cure for Hepatitis C.
In the first-of-its-kind study dedicated to patients with Hepatitis C and cirrhosis of the liver, Dr. Fred Poordad announced to the International Liver Congress in London over the weekend a new medicine that eradicated the Hepatitic C virus in more than 90 percent of patients studied.
Poordad is a professor of medicine at the UT Health Science Center School of Medicine and vice president of the Texas Liver Institute and the lead author of the study.
On Friday the FDA approved a new drug that, when taken in conjunction with other older remedies, cures 95 percent of Hepatitis C patients in a fraction of the time the old treatment regimen did. Hepatitis C, the liver degenerating disease, affects over three million U.S. citizens, and, surpassing HIV, last year killed over 15,000 people.
A San Antonio research team has uncovered a way to cure the deadly Hepatitis C – promising shorter treatments and fewer side effects than today’s standard treatment.
Hepatitis C can be treated today with a battery of interferon interventions treatments -- which takes 48 weeks and the side effects are debilitating -- but a new treatment using a combination of drugs needs only 12 weeks to kill the virus with much fewer side effects.